Bleeding disorders are severe conditions that have an effect on a large number of people about the world. Hemophilia alone affects almost 20,000 folks in the United States and more than 400 youngsters are born every year with the disorder. Severe circumstances of hemophilia happen practically predominantly in men women can still be carriers of the gene that causes hemophilia, but only create mild forms of the bleeding disorder.

Other forms of bleeding disorders include:

Acquired platelet function defects
Congenital platelet function defects
Congenital antithrombin III deficiency
Congenital protein C or S deficiency
Disseminated intravascular coagulation (DIC)
Drug-induced immune thrombocytopenia
Factor II deficiency
Factor V deficiency
Factor VII deficiency
Factor X deficiency
Factor XII
Idiopathic thrombocytopenic purpura (ITP)
Von Willebrand’s illness

Bleeding disorders can result from a number of different causes and can be either inherited or acquired. The most common element of these disorders is a lack of the blood parts responsible for clotting (platelets). The result is excessive or heavy bleeding that takes longer for the body to control.

In the very first half of the 20th century, it was frequent for hemophilia patients and patients with other clotting disorders to be treated with blood transfusions. The procedure initially involved the transfusion of complete blood or frozen plasma. This was a laborious procedure, requiring extended hospital stays for each and every treatment.

During the 1970s and 80s, the distinct clotting factors in the blood became offered in more convenient, concentrated forms. Considering that the clotting elements had been the only parts of the blood that hemophiliacs and other patients with bleeding disorders required from the whole blood or plasma, blood transfusions were no longer required.

Unfortunately, whether acquired from blood transfusions or by way of concentrated plasma extracts, the necessary platelets still had to come from donor blood banks. By 1987, it became evident that an alarming number of hemophiliac and other bleeding disorder patients had turn into infected with hepatitis B, hepatitis C, and HIV (the virus that causes AIDS) due to contaminated donor blood.

Even though key strides have been produced because the late 1980s to enhance the safety of donor blood, there are still a number of risks linked with receiving donated blood parts by means of blood transfusions or other approaches. Patients with hemophilia and other bleeding disorders are at danger for any blood borne pathogen, allergic reactions and a number of other complications that can result from receiving donor blood parts or the transfusion procedure itself.

The advent of bloodless medicine, which includes bloodless surgery and a substantial , has supplied new alternatives for treating hemophilia and other bleeding disorders. The field of bloodless medicine entails a number of diverse strategies and new technologies that can minimize the loss of blood in the course of main surgeries. Luckily for hemophiliacs and patients with similar bleeding disorders, numerous of the fundamentals and techniques employed in blood management can be applied to the treatment of these illnesses.

1 such method entails a gene modified bone marrow transplant. The patients own bone marrow is removed and the stem cells contained in it are treated with Factor VIII – a clotting factor, which is placed in the platelets. The modified bone marrow is transplanted back to the patient, who is now able to generate blood platelets retaining the essential clotting mechanisms that stop internal and external bleeding.

For individuals suffering from hemophilia and other bleeding disorders, blood management remedies such as these do a lot more than simply eliminate the need for a potentially danger blood transfusion. These new kinds of remedies also have the prospective to enable patients to lead a much more “regular” life, with out frequent hospital visits. Some hemophiliacs require frequent blood transfusions – as numerous as three per week. Newer treatments utilizing blood management strategies and analysis have the prospective to drastically decrease treatment times.  

Contact your neighborhood hospital or healthcare system for more data about blood management and any bloodless medicine programs that may be available near you.